Plain-English translation of NCT06663969 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a newer approach called temporal interference (TI) — a non-invasive way to stimulate deep areas of the brain. Researchers will use this technique on people with drug-resistant epilepsy who already have implanted brain monitoring electrodes. By recording how your brain responds to the treatment, the study aims to understand how temporal interference works and whether it could one day replace more invasive procedures.
Many people with epilepsy don't respond to medications, and current deep brain stimulation treatments require surgery to implant permanent devices. This trial explores whether the new treatment could provide a safer, non-invasive option that achieves similar results.
You likely qualify if…
You likely don't qualify if…
You would undergo temporal interference stimulation while researchers monitor your brain's electrical activity using your already-implanted electrodes. Researchers will record your brain activity and any clinical changes before, during, and after each stimulation session. The study involves observation and data collection rather than ongoing medication or lengthy treatment — the focus is on understanding how your brain responds to this new stimulation method.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
China
Sponsor
Xuanwu Hospital, Beijing
Enrollment target
~20 participants
Started
November 2024
Primary completion
September 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
14 Years – 65 Years
Last updated on clinicaltrials.gov in February 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Liankun Ren, MD
Xuanwu Hospital, Beijing
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.